Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
Moderna
MRNA
|
+$281M |
| 2 |
Amazon
AMZN
|
+$231M |
| 3 |
Citizens Financial Group
CFG
|
+$207M |
| 4 |
Apple
AAPL
|
+$207M |
| 5 |
Amgen
AMGN
|
+$196M |
Top Sells
Sector Composition
| 1 | Technology | 20.61% |
| 2 | Financials | 13.44% |
| 3 | Healthcare | 12.08% |
| 4 | Consumer Discretionary | 10.79% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3001
SPDR Portfolio TIPS ETF
SPIP
$990M
| $727K | ﹤0.01% |
23,380
+814
| +4% | +$25.3K |
|
|
ATHX
3002
DELISTED
Athersys, Inc. Common Stock
ATHX
| $726K | ﹤0.01% |
21,812
+2,095
| +11% | +$69.7K |
|
3003
First Internet Bancorp
INBK
$210M
| $723K | ﹤0.01% |
23,162
| – | – |
|
3004
European Wax Center
EWCZ
$165M
| $722K | ﹤0.01% |
+25,741
| New | +$722K |
|
3005
Applied Therapeutics
APLT
$63.7M
| $720K | ﹤0.01% |
43,336
-317
| -0.7% | -$5.27K |
|
3006
UroGen Pharma
URGN
$913M
| $719K | ﹤0.01% |
42,689
+2,174
| +5% | +$36.6K |
|
3007
Park Aerospace
PKE
$381M
| $717K | ﹤0.01% |
52,409
-76,980
| -59% | -$1.05M |
|
3008
CoreCard
CCRD
$212M
| $716K | ﹤0.01% |
17,614
+176
| +1% | +$7.15K |
|
3009
Distribution Solutions Group
DSGR
$1.46B
| $715K | ﹤0.01% |
28,588
+2,006
| +8% | +$50.2K |
|
3010
South Plains Financial
SPFI
$660M
| $714K | ﹤0.01% |
29,263
+2,276
| +8% | +$55.5K |
|
|
BFX
3011
DELISTED
BowFlex Inc.
BFX
| $714K | ﹤0.01% |
76,586
+1,981
| +3% | +$18.5K |
|
|
BNFT
3012
DELISTED
Benefitfocus, Inc.
BNFT
| $714K | ﹤0.01% |
64,308
-131,676
| -67% | -$1.46M |
|
3013
Aterian
ATER
$9.49M
| $712K | ﹤0.01% |
5,478
+1,429
| +35% | +$186K |
|
|
AKUS
3014
DELISTED
Akouos, Inc. Common Stock
AKUS
| $710K | ﹤0.01% |
61,102
-50,682
| -45% | -$589K |
|
3015
Superior Group of Companies
SGC
$191M
| $709K | ﹤0.01% |
30,422
+2,198
| +8% | +$51.2K |
|
3016
Stereotaxis
STXS
$262M
| $707K | ﹤0.01% |
131,290
+3,367
| +3% | +$18.1K |
|
3017
Tenaya Therapeutics
TNYA
$210M
| $707K | ﹤0.01% |
+34,211
| New | +$707K |
|
3018
CuriosityStream
CURI
$256M
| $706K | ﹤0.01% |
66,979
+3,714
| +6% | +$39.1K |
|
3019
TherapeuticsMD
TXMD
$12.7M
| $706K | ﹤0.01% |
19,021
-30,758
| -62% | -$1.14M |
|
3020
Janux Therapeutics
JANX
$1.48B
| $705K | ﹤0.01% |
+32,576
| New | +$705K |
|
|
TAST
3021
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $705K | ﹤0.01% |
192,432
-167,829
| -47% | -$615K |
|
3022
Eterna Therapeutics
ERNA
$11.1M
| $701K | ﹤0.01% |
251
+57
| +29% | +$159K |
|
|
FNCH
3023
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
| $697K | ﹤0.01% |
1,786
+140
| +9% | +$54.6K |
|
3024
Foghorn Therapeutics
FHTX
$304M
| $696K | ﹤0.01% |
49,958
-21,403
| -30% | -$298K |
|
|
SMMF
3025
DELISTED
Summit Financial Group, Inc.
SMMF
| $693K | ﹤0.01% |
28,242
| – | – |
|